Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04349475 · ClinicalTrials.gov registry record · NA

Therapeutic Omegas for Triglyceride Suppression

A NA study of Pregnancy, sponsored by University of Colorado, Denver.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
2
Study locations

NCT04349475: Recruiting NA study of Pregnancy, sponsored by University of Colorado, Denver.

NCT04349475 is a NA study of Pregnancy that is actively recruiting participants, run by University of Colorado, Denver. The registered enrollment target is 40 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (95% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04349475, a NA study of Pregnancy, is actively recruiting participants, sponsored by University of Colorado, Denver.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
2
Study locations

Study Summary

This study plans to learn more about how an omega-3 fatty acid supplement effects triglyceride levels in pregnancy. Triglycerides are a type of fat found in your blood. Your body converts extra calories into triglycerides to be stored and used later for energy. It is normal for triglyceride levels to go up during pregnancy however some women have levels that are \~30-40% higher than normal when they reach their third trimester of pregnancy. Having high triglycerides in pregnancy may be related to an increased chance of having a baby that is large for their age. The goal of this study is to determine if taking an omega-3 fatty acid supplement can slow the rise in triglyceride levels later in pregnancy.

Primary Outcome

Differences in maternal fasting and postprandial triglycerides between groups

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Intervention Omega 3 Supplementation
  • DIETARY_SUPPLEMENT Control Safflower Oil

Study Locations (2)

Colorado

  • University of Colorado/Anschutz Medical Campus - Aurora

Oklahoma

  • University of Oklahoma Health Sciences Center - Oklahoma City

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2021-11-29
Est. Completion 2025-12-31
Phase NA
University of Colorado, Denver

1,283 total trials

What NCT04349475 shows while recruiting

NCT04349475 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (95% lower).

The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Intervention Omega 3 Supplementation is the first listed.

NCT04349475 reports a single indexed study location in Colorado, Oklahoma.

Frequently Asked Questions

What is clinical trial NCT04349475 about?

NCT04349475 is a clinical study titled "Therapeutic Omegas for Triglyceride Suppression". This study plans to learn more about how an omega-3 fatty acid supplement effects triglyceride levels in pregnancy. Triglycerides are a type of fat found in your blood. Your body converts extra calories into triglycerides to be stored and used later for energy. It is normal for triglyceride levels t...

What is the current status of trial NCT04349475?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2021-11-29. Estimated completion is 2025-12-31.

What conditions does trial NCT04349475 study?

This clinical trial studies the following conditions: Pregnancy.

What interventions are being tested in trial NCT04349475?

The interventions under investigation include: Intervention Omega 3 Supplementation (DIETARY_SUPPLEMENT), Control Safflower Oil (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT04349475?

This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04349475 being conducted?

This trial has 2 study locations across Colorado, Oklahoma. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04349475's enrollment target sits among peer trials

40 162nd of 191 higher than 27 of 191 other Pregnancy trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01306019 · 40 participants · Phase 1

    Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

  • NCT01608152 · 40 participants

    Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors

  • NCT01668082 · 40 participants · NA

    An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection

  • NCT02015013 · 40 participants · Phase 2

    Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04349475, the US trial registry maintained by the National Library of Medicine. NCT04349475 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.